Biological Evaluation and SAR Exploration of Bile Acid–Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer
Biomolecules · 2026
DOI: 10.3390/biom16010177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Daniela Perrone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Artemisinins, Antineoplastic Agents, Colorectal Neoplasms, Bile Acids and Salts. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dihydroartemisinin (DHA), a first-line treatment for uncomplicated malaria, has demonstrated antitumor activity against a variety of human cancers, emphasizing its potential for repurposing as an anticancer agent. However, its short half-life and poor bioavailability hinder its application in cancer therapy. We previously demonstrated that the molecular hybridization of DHA with bile acids (BAs) enhances its anticancer activity by improving stability and reducing toxicity. Based on this rationale, here, we designed and synthesized a library of DHA-based hybrids through conjugation with ursodeoxycholic and chenodeoxycholic bile acids. Different conjugation sites and both cleavable and non-cleavable linkages were explored to enable a comprehensive structure–activity relationship analysis. The resulting BA-DHA hybrids were evaluated in vitro for their anticancer activity against HCT116 and RKO colorectal cancer cell lines. As a result of the synergistic effect of the linker type and conjugation site, the BA-DHA hybrids synthesized via click chemistry emerged as the most active compounds in both cell lines, displaying 2- to 20-fold higher activity than the parent DHA. Mechanistic investigations further revealed that the click-derived BA-DHA hybrids possess enhanced anticancer activity and antimetastatic potential, achieving comparable or even superior efficacy to the parent compound at markedly lower concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
- Department of Environmental and Prevention Sciences and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR), 40129 Bologna, Italy.
ORCID-Profile: Daniela Perrone, Elisabetta Melloni, Lorenzo Gnudi, Fabio Casciano, Elena Pozza, Francesca Bompan, Elena Marchesi, Maria Luisa Navacchia
Zitieren
APA
Perrone, D., Melloni, E., Gnudi, L., Casciano, F., Pozza, E., Bompan, F., Secchiero, P., Marchesi, E., & Navacchia, M. L. (2026). Biological Evaluation and SAR Exploration of Bile Acid–Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer. Biomolecules. https://doi.org/10.3390/biom16010177
Vancouver
Perrone D, Melloni E, Gnudi L, Casciano F, Pozza E, Bompan F, et al. Biological Evaluation and SAR Exploration of Bile Acid–Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer. Biomolecules. 2026. doi:10.3390/biom16010177
BibTeX
@article{Perrone2026,
author = {Perrone, Daniela and Melloni, Elisabetta and Gnudi, Lorenzo and Casciano, Fabio and Pozza, Elena and Bompan, Francesca and Secchiero, Paola and Marchesi, Elena and Navacchia, Maria Luisa},
title = {Biological Evaluation and SAR Exploration of Bile Acid–Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16010177}
}
EUVIMED